https://www.biospace.com/syndax-pharmaceuticals-announces-additional-positive-data-demonstrating-continued-robust-clinical-activity-with-durable-responses-in-phase-1-portion-of-augment-101-trial-of-sndx-5613
Syndax Pharmaceuticals Announces Additional Positive Data Demonstrating Continued Robust Clinical...
Dec 13, 2021 - Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), today announced updated positive data from the Phase 1 dose escalation portion...
syndaxpharmaceuticalsannouncesadditionalpositive
https://www.baadertrading.de/aktien/1T3-GTX
SYNDAX PHARMACEUTICALS, INC. | 1T3.GTX | US87164F1057 | A2AFL6 - Baader Trading
SYNDAX PHARMACEUTICALS, INC. | 1T3.GTX | US87164F1057 | A2AFL6 - Live-Charts in Realtime, Aktien-Kurse, News und mehr + Jetzt bei Baader Trading handeln!
syndaxpharmaceuticalsincgtxbaader
https://syndax.com/patients/
Patients - Syndax
patientssyndax
https://www.vcnewsdaily.com/Syndax/venture-funding.php
Syndax Venture Capital and Private Equity Financings
VC News Daily provides funding details on Venture Capital backed startups.
venture capitalprivate equitysyndaxfinancings
https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302107801.html
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies,...
syndaxpharmaceuticalsreportsgrantsnasdaq
https://pharsight.greyb.com/company/syndax-drug-patent-portfolio
Syndax Drug Patent Portfolio
Explore the complete list of drugs in Syndax's Drug Patent Portfolio, along with the list of patents protecting each drug.
patent portfoliosyndaxdrug